ahlam1399
02-18-2016, 03:40 PM
Zafgen?s obesity drug succeeds in mid-stage trial
(Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4dadc92d/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=u3tv2UZDKss:E1eqbS49_LE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=u3tv2UZDKss:E1eqbS49_LE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/u3tv2UZDKss
(Reuters) - Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4dadc92d/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=u3tv2UZDKss:E1eqbS49_LE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=u3tv2UZDKss:E1eqbS49_LE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=u3tv2UZDKss:E1eqbS49_LE:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/u3tv2UZDKss